title: Subsidised use of methylnaltrexone in Australia for palliative care.
authors.forename: Debra S
authors.initials: DS
authors.lastname: Rowett
authors.forename: Katherine
authors.initials: K
authors.lastname: Clark
authors.forename: Maxine K
authors.initials: MK
authors.lastname: Robinson
authors.forename: David C
authors.initials: DC
authors.lastname: Currow
mesh_terms: D000701:Analgesics, Opioid / Q000009:adverse effects; D001315:Australia; D003248:Constipation / Q000139:chemically induced / Q000188:drug therapy*; D004363:Drug Utilization; D006801:Humans; D054368:Laxatives / Q000627:therapeutic use*; D009271:Naltrexone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D010166:Palliative Care; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use
chemical_list: D000701:Analgesics, Opioid; D054368:Laxatives; D009292:Narcotic Antagonists; D000644:Quaternary Ammonium Compounds; C032257:methylnaltrexone; D009271:Naltrexone